UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Target Level for Hemoglobin Correction in Patients With Diabetes and CKD: Primary Results of the Anemia Correction in Diabetes (ACORD) Study

American journal of kidney diseases, 2007-02, Vol.49 (2), p.194-207

2007

Volltextzugriff (PDF)

Effect of Once-Weekly Epoetin Beta on Survival in Patients With Metastatic Breast Cancer Receiving Anthracycline- and/or Taxane-Based Chemotherapy: Results of the Breast Cancer—Anemia and the Value of Erythropoietin (BRAVE) Study

Journal of clinical oncology, 2008-02, Vol.26 (4), p.592-598

2008

Volltextzugriff (PDF)

Effectiveness and safety of recombinant human erythropoietin beta in maintaining common haemoglobin targets in routine clinical practice in Europe: the GAIN study

Current medical research and opinion, 2009-04, Vol.25 (4), p.961-970

2009

Volltextzugriff (PDF)

Impact of Pulmonary Disease on Noninvasive Measurement of Cardiac Output by the Inert Gas Rebreathing Method

Lung, 2010-10, Vol.188 (5), p.433-440

2010

Volltextzugriff (PDF)

The Safety of Amiodarone in Patients With Heart Failure

Journal of cardiac failure, 2007-06, Vol.13 (5), p.340-345

2007

Volltextzugriff (PDF)

Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN)

European journal of heart failure, 2004-06, Vol.6 (4), p.467-475

2004

Volltextzugriff (PDF)

Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia

The New England journal of medicine, 2006-11, Vol.355 (20), p.2071-2084

2006

Volltextzugriff (PDF)

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

The Lancet (British edition), 2003-07, Vol.362 (9377), p.7-13

2003

Volltextzugriff (PDF)

Carvedilol Protects Better Against Vascular Events Than Metoprolol in Heart Failure

Journal of the American College of Cardiology, 2007-03, Vol.49 (9), p.963-971

2007

Volltextzugriff (PDF)

Correction towards Normal Hemoglobin Values in Chronic Kidney Disease: What Is the Current Evidence regarding Mortality and Morbidity Outcomes?

Kidney & blood pressure research, 2009-01, Vol.32 (1), p.1-10

Scherhag, Armin

2009

Volltextzugriff (PDF)

Left Ventricular Geometry Predicts Cardiovascular Outcomes Associated with Anemia Correction in CKD

Journal of the American Society of Nephrology, 2009-12, Vol.20 (12), p.2651-2660

2009

Volltextzugriff (PDF)

Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial

European heart journal, 2005-11, Vol.26 (21), p.2259-2268

2005

Volltextzugriff (PDF)

Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET)

Heart (British Cardiac Society), 2007-08, Vol.93 (8), p.968-973

2007

Volltextzugriff (PDF)

In Reply

American journal of kidney diseases, 2007-08, Vol.50 (2), p.344

2007

Volltextzugriff (PDF)

Hepcidin as a Predictor of Response to Epoetin Therapy in Anemic Cancer Patients

Clinical chemistry (Baltimore, Md.), 2009-07, Vol.55 (7), p.1354-1360

2009

Volltextzugriff (PDF)

Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study

Journal of the American College of Cardiology, 2004-04, Vol.43 (8), p.1423-1429

2004

Volltextzugriff (PDF)

Basic in vitro Characterization of the Vasodilatory Potential of 2-Aminoethyl Nitrate Fixed-Dose Combinations with Cilostazol, Metoprolol and Valsartan

Pharmacology, 2018-01, Vol.101 (1-2), p.54-63

2018

Volltextzugriff (PDF)

Carvedilol protects better against vascular events than metoprolol in heart failure : Results from COMET

Journal of the American College of Cardiology, 2007-03, Vol.49 (9), p.963-971

2007

Volltextzugriff (PDF)

Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a β-blocker: Results from the Carvedilol Or Metoprolol European Trial (COMET) trial

European journal of heart failure, 2007-08, Vol.9 (8), p.795-801

2007

Volltextzugriff (PDF)

Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure—COMET

The American heart journal, 2005-02, Vol.149 (2), p.370-376

2005

Volltextzugriff (PDF)

The influence of Erythropoietin on platelet activation, thrombin generation and FVII/active FVII in patients with AMI

Thrombosis journal, 2014-08, Vol.12 (1), p.18-18, Article 18

2014

Volltextzugriff (PDF)

The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild Heart failure evaluation trial (CARMEN)

Cardiovascular drugs and therapy, 2004, Vol.18 (1), p.57-66

2004

Volltextzugriff (PDF)

What is the impact of antithrombotic therapy and risk factors on the frequency of thrombovascular events in patients with metastatic breast cancer receiving epoetin beta?

European journal of cancer (1990), 2009-11, Vol.45 (17), p.2984-2991

2009

Volltextzugriff (PDF)

In vitro and in vivo Characterization of a New Organic Nitrate Hybrid Drug Covalently Bound to Pioglitazone

Pharmacology, 2014-01, Vol.93 (5-6), p.203-215

2014

Volltextzugriff (PDF)

Effect of computer-assisted European Best Practice Guideline implementation on adherence and target attainment: ORAMA results

Journal of nephrology, 2009-09, Vol.22 (5), p.662-674

2009

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(51)
Buchkapitel
(1)

Sprache

Englisch
(51)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(35)
Science & Technology
(35)
Humans
(32)
Male
(29)
Female
(28)
Middle Aged
(27)
Aged
(21)
Biological And Medical Sciences
(17)
Medical Sciences
(17)
Cardiovascular System & Cardiology
(16)
Cardiac & Cardiovascular Systems
(12)
Heart Failure - Drug Therapy
(12)
Adrenergic Beta-Antagonists - Therapeutic Use
(11)
Heart Failure
(11)
Adult
(10)
Carbazoles - Therapeutic Use
(10)
Cardiology
(10)
Propanolamines - Therapeutic Use
(10)
Recombinant Proteins
(10)
Treatment Outcome
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Target Level for Hemoglobin Correction in Patients With Diabetes and CKD: Primary Results of the Anemia Correction in Diabetes (ACORD) Study

Effect of Once-Weekly Epoetin Beta on Survival in Patients With Metastatic Breast Cancer Receiving Anthracycline- and/or Taxane-Based Chemotherapy: Results of the Breast Cancer—Anemia and the Value of Erythropoietin (BRAVE) Study

Effectiveness and safety of recombinant human erythropoietin beta in maintaining common haemoglobin targets in routine clinical practice in Europe: the GAIN study

Impact of Pulmonary Disease on Noninvasive Measurement of Cardiac Output by the Inert Gas Rebreathing Method

The Safety of Amiodarone in Patients With Heart Failure

Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN)

Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

Carvedilol Protects Better Against Vascular Events Than Metoprolol in Heart Failure

Correction towards Normal Hemoglobin Values in Chronic Kidney Disease: What Is the Current Evidence regarding Mortality and Morbidity Outcomes?

Left Ventricular Geometry Predicts Cardiovascular Outcomes Associated with Anemia Correction in CKD

Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial

Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET)

In Reply

Hepcidin as a Predictor of Response to Epoetin Therapy in Anemic Cancer Patients

Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study

Basic in vitro Characterization of the Vasodilatory Potential of 2-Aminoethyl Nitrate Fixed-Dose Combinations with Cilostazol, Metoprolol and Valsartan

Carvedilol protects better against vascular events than metoprolol in heart failure : Results from COMET

Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a β-blocker: Results from the Carvedilol Or Metoprolol European Trial (COMET) trial

Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure—COMET

The influence of Erythropoietin on platelet activation, thrombin generation and FVII/active FVII in patients with AMI

The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild Heart failure evaluation trial (CARMEN)

What is the impact of antithrombotic therapy and risk factors on the frequency of thrombovascular events in patients with metastatic breast cancer receiving epoetin beta?

In vitro and in vivo Characterization of a New Organic Nitrate Hybrid Drug Covalently Bound to Pioglitazone

Effect of computer-assisted European Best Practice Guideline implementation on adherence and target attainment: ORAMA results

Suchergebnisse filtern